Jane Henderson - Insider Trading & Ownership

Location
C/O Eleven Biotherapeutics, Inc., 215 First Street, Cambridge, MA
Summary
The estimated net worth of Jane Henderson is at least $13.3M dollars as of November 14, 2025. Jane Henderson is the Chief Financial Officer of Apogee Therapeutics, Inc. and owns shares of Apogee Therapeutics, Inc. (APGE) stock worth about $12.9M. Jane Henderson is the Director of Akero Therapeutics, Inc. and owns shares of Akero Therapeutics, Inc. (AKRO) stock worth about $446K.
Signature
/s/ Matthew Batters, as attorney-in-fact for Jane Pritchett Henderson
All Insider Reports
All Insider Reports

Ownership of Jane Henderson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APGE Apogee Therapeutics, Inc. Chief Financial Officer $12.9M -$190K -1.46% Nov 14, 2025
AKRO Akero Therapeutics, Inc. Director $446K -$142K -24.2% Aug 12, 2025
IVVD Invivyd, Inc. Chief Financial Officer Jan 30, 2022
CRGX CARGO Therapeutics, Inc. Director Aug 19, 2025
ISEE IVERIC bio, Inc. Director Jul 11, 2023
CARM Carisma Therapeutics Inc. Director May 3, 2021

Insider Transactions Reported by Jane Henderson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.